BCHE and cancer: As evidenced by Figures 12A, B, BCHE is more pronounced in populations with lower differentiation (G3), later clinical and T-stages, death patients, as well as subgroups with shorter PFI, DFI, and DSS, indicating that BCHE may be an oncogene that can induce cancer development and lead to poor prognosis.